课题基金 / 基金详情

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
1/2 促进癌症研究的伙伴关系:NMSU
批准号:
10463668
负责人:
Julian A Simon
金额:
$114.69万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2023-08-31

项目摘要

项目成果

Julian A Simon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Partnership for the Advancement of Cancer Research: NMSU – Fred Hutch Multiple PIs: Graciela A. Unguez, Mary O'Connell (NMSU) and Julian Simon, Beti Thompson (Fred Hutch) [The content of the Overall Section is identical in the NMSU and Fred Hutch proposals.] PROJECT SUMMARY/ABSTRACT The U54 Partnership between New Mexico State University (NMSU), an Institution Serving Underserved Health Disparities Populations and Underrepresented Students (ISUPS), and Fred Hutchinson Cancer Research Center (Fred Hutch) a major cancer center, is a mature mutually beneficial partnership; the two institutions worked together on a U56 (2002-2007) and two cycles of a U54 (2007 – 2018). In our 15-year Partnership, we have accomplished many goals; for example, NMSU now has a strong cancer research infrastructure and Fred Hutch is increasing its attention to health disparities research. Our overall goals for this U54 cycle are to increase and maintain our excellence in the cancer research portfolio, cancer education, and outreach and dissemination; further, we will expand our efforts to develop leaders in cancer research and cancer health disparities research. Five specific aims will help us achieve our overall goals to: (1) Continue to develop a diverse portfolio of robust cancer research projects that span clinical, basic, and population health sciences; (2) Collaborate with regional community organizations that work with underrepresented populations to reduce cancer health disparities; (3) Maintain, strengthen, and evaluate our effective research education programs for current and future underrepresented scientists; (4) Continue to implement evidence-based relevant cancer-related public health interventions within underrepresented communities; and (5) Expand the scientific collaboration among U54 Partnership members and other faculty within the two institutions. To achieve these aims, we have assembled a broad portfolio of innovative cancer research projects (two full research projects and two pilot research projects) that each address an unmet regional need among underrepresented populations. Recent emphasis on health disparities represents a shift in the focus of our Partnership from basic to public health science research projects. These projects benefit from strong community input. In addition to the four research projects, we propose five cores: Administrative, Planning and Evaluation, Research Education About Cancer and Health (REACH), Outreach and Sustain Competitive Cancer Early Stage Scientists (SuCCESS) Cores that promote the development of cancer research, education, community collaboration, in-reach, and outreach. The Partnership has and will continue to play a unique and critical role in both institutions' efforts to increase recruitment and retention of underrepresented individuals in the biomedical research pipeline. Additionally, the Partnership has significantly increased cancer research capacity at NMSU, while also increasing participation in health disparities research at Fred Hutch—both institutions have benefited substantially from the Partnership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
海外基金